Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 80
Filtrar
1.
Breast Cancer Res Treat ; 206(2): 317-328, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38561577

RESUMO

PURPOSE: To evaluate the efficacy and safety of first-line therapy with palbociclib in a Spanish cohort treated after palbociclib approval. METHODS: PALBOSPAIN is an observational, retrospective, multicenter study evaluating real-world patterns and outcomes with 1 L palbociclib in men and women (any menopausal status) with advanced HR+/HER2- BC diagnosed between November 2017 and November 2019. The primary endpoint was real-world progression-free survival (rw-PFS). Secondary endpoints included overall survival (OS), the real-world response rate (rw-RR), the clinical benefit rate, palbociclib dose reduction, and safety. RESULTS: A total of 762 patients were included. The median rw-PFS and OS were 24 months (95% CI 21-27) and 42 months (40-not estimable [NE]) in the whole population, respectively. By cohort, the median rw-PFS and OS were as follows: 28 (95% CI 23-39) and 44 (95% CI 38-NE) months in patients with de novo metastatic disease, 13 (95% CI 11-17) and 36 months (95% CI 31-41) in patients who experienced relapse < 12 months after the end of ET, and 31 months (95% CI 26-37) and not reached (NR) in patients who experienced relapse > 12 months after the end of ET. rw-PFS and OS were longer in patients with oligometastasis and only one metastatic site and those with non-visceral disease. The most frequent hematologic toxicity was neutropenia (72%; grade ≥ 3: 52.5%), and the most common non-hematologic adverse event was asthenia (38%). CONCLUSION: These findings, consistent with those from clinical trials, support use of palbociclib plus ET as 1 L for advanced BC in the real-world setting, including pre-menopausal women and men. TRIAL REGISTRATION NUMBER: NCT04874025 (PALBOSPAIN). Date of registration: 04/30/2021 retrospectively registered.


Assuntos
Neoplasias da Mama , Piperazinas , Piridinas , Receptor ErbB-2 , Humanos , Piridinas/uso terapêutico , Piridinas/efeitos adversos , Piridinas/administração & dosagem , Feminino , Piperazinas/uso terapêutico , Piperazinas/administração & dosagem , Piperazinas/efeitos adversos , Pessoa de Meia-Idade , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Neoplasias da Mama/mortalidade , Neoplasias da Mama/metabolismo , Idoso , Adulto , Masculino , Estudos Retrospectivos , Receptor ErbB-2/metabolismo , Idoso de 80 Anos ou mais , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Inibidores de Proteínas Quinases/uso terapêutico , Inibidores de Proteínas Quinases/efeitos adversos , Inibidores de Proteínas Quinases/administração & dosagem , Intervalo Livre de Progressão
2.
Actas Dermosifiliogr (Engl Ed) ; 112(4): 357-358, 2021 Apr.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-33127421

Assuntos
Dor , Coxa da Perna , Humanos
4.
Actas dermo-sifiliogr. (Ed. impr.) ; 111(6): 471-480, jul.-ago. 2020. graf, ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-199503

RESUMO

La aftosis oral recidivante es una enfermedad inflamatoria crónica de la mucosa oral. Se caracteriza por presentar úlceras dolorosas en la cavidad oral sin que se encuentre una enfermedad subyacente que lo justifique. Ante la aparición de úlceras recidivantes en la mucosa oral habrá que realizar un correcto diagnóstico diferencial y descartar otras causas antes de llegar al diagnóstico de aftosis oral recidivante. Se trata de una enfermedad frecuente; según la población estudiada, se han documentado prevalencias entre el 5 y el 60%. Su patogenia es desconocida, pero se considera multifactorial. El tratamiento no está estandarizado y no es curativo, se pretende disminuir el dolor durante el brote, acortar la duración del mismo y evitar la aparición de nuevas lesiones


Recurrent aphthous stomatitis is a chronic inflammatory disease of the oral mucosa. It is characterized by painful mouth ulcers that cannot be explained by an underlying disease. Recurrent oral mucosal ulcers require a proper differential diagnosis to rule out other possible causes before recurrent aphthous stomatitis is diagnosed. The condition is common, with prevalence rates ranging from 5 to 60% in different series. Its pathogenesis is unknown, but multiple factors are considered to play a part. There are no standardized treatments for this condition and none of the treatments are curative. The goal of any treatment should be to alleviate pain, reduce the duration of ulcers, and prevent recurrence


Assuntos
Humanos , Estomatite Aftosa/diagnóstico , Estomatite Aftosa/etiologia , Estomatite Aftosa/terapia , Diagnóstico Diferencial , Fatores de Risco , Recidiva
6.
Actas Dermosifiliogr (Engl Ed) ; 111(6): 471-480, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32451064

RESUMO

Recurrent aphthous stomatitis is a chronic inflammatory disease of the oral mucosa. It is characterized by painful mouth ulcers that cannot be explained by an underlying disease. Recurrent oral mucosal ulcers require a proper differential diagnosis to rule out other possible causes before recurrent aphthous stomatitis is diagnosed. The condition is common, with prevalence rates ranging from 5 to 60% in different series. Its pathogenesis is unknown, but multiple factors are considered to play a part. There are no standardized treatments for this condition and none of the treatments are curative. The goal of any treatment should be to alleviate pain, reduce the duration of ulcers, and prevent recurrence.


Assuntos
Úlceras Orais , Estomatite Aftosa , Humanos , Mucosa Bucal , Dor , Recidiva , Estomatite Aftosa/diagnóstico
7.
J Proteomics ; 221: 103757, 2020 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-32247173

RESUMO

Atherosclerosis remains the leading cause of ischemic syndromes such as myocardial infarction or brain stroke, mainly promoted by plaque rupture and subsequent arterial blockade. Identification of vulnerable or high-risk plaques constitutes a major challenge, being necessary to identify patients at risk of occlusive events in order to provide them with appropriate therapies. Clinical imaging tools have allowed the identification of certain structural indicators of prone-rupture plaques, including a necrotic lipidic core, intimal and adventitial inflammation, extracellular matrix dysregulation, and smooth muscle cell depletion and micro-calcification. Additionally, alternative approaches focused on identifying molecular biomarkers of atherosclerosis have also been applied. Among them, proteomics has provided numerous protein markers currently investigated in clinical practice. In this regard, it is quite uncertain that a single molecule can describe plaque rupture, due to the complexity of the process itself. Therefore, it should be more accurate to consider a set of markers to define plaques at risk. Herein, we propose a selection of 76 proteins, from classical inflammatory to recently related markers, all of them identified in at least two proteomic studies analyzing unstable atherosclerotic plaques. Such panel could be used as a prognostic signature of plaque instability.


Assuntos
Aterosclerose , Placa Aterosclerótica , Biomarcadores , Humanos , Inflamação , Proteômica
8.
Leukemia ; 34(10): 2648-2659, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32107471

RESUMO

Myelofibrosis (MF) occurs as part of the natural history of polycythemia vera (PV) and essential thrombocythemia (ET), and remarkably shortens survival. Although JAK2V617F and CALR allele burden are the main transformation risk factors, inflammation plays a critical role by driving clonal expansion toward end-stage disease. NF-κB is a key mediator of inflammation-induced carcinogenesis. Here, we explored the involvement of miR-146a, a brake in NF-κB signaling, in MPN susceptibility and progression. rs2910164 and rs2431697, that affect miR-146a expression, were analyzed in 967 MPN (320 PV/333 ET/314 MF) patients and 600 controls. We found that rs2431697 TT genotype was associated with MF, particularly with post-PV/ET MF (HR = 1.5; p < 0.05). Among 232 PV/ET patients (follow-up time=8.5 years), 18 (7.8%) progressed to MF, being MF-free-survival shorter for rs2431697 TT than CC + CT patients (p = 0.01). Multivariate analysis identified TT genotype as independent predictor of MF progression. In addition, TT (vs. CC + CT) patients showed increased plasma inflammatory cytokines. Finally, miR-146a-/- mice showed significantly higher Stat3 activity with aging, parallel to the development of the MF-like phenotype. In conclusion, we demonstrated that rs2431697 TT genotype is an early predictor of MF progression independent of the JAK2V617F allele burden. Low levels of miR-146a contribute to the MF phenotype by increasing Stat3 signaling.


Assuntos
MicroRNAs/genética , Transtornos Mieloproliferativos/genética , Mielofibrose Primária/genética , Idoso , Alelos , Animais , Citocinas/genética , Progressão da Doença , Feminino , Genótipo , Humanos , Inflamação/genética , Inflamação/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Mutação/genética , Transtornos Mieloproliferativos/patologia , NF-kappa B/genética , Policitemia Vera/genética , Policitemia Vera/patologia , Transdução de Sinais/genética , Trombocitemia Essencial/genética , Trombocitemia Essencial/patologia
9.
J Autoimmun ; 82: 31-40, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28465139

RESUMO

OBJECTIVES: 1) To assess the association of NETosis and NETosis-derived products with the activity of the disease and the development of cardiovascular disease in RA; 2) To evaluate the involvement of NETosis on the effects of biologic therapies such as anti-TNF alpha (Infliximab) and anti-IL6R drugs (Tocilizumab). METHODS: One hundred and six RA patients and 40 healthy donors were evaluated for the occurrence of NETosis. Carotid-intimae media thickness was analyzed as early atherosclerosis marker. Inflammatory and oxidative stress mediators were quantified in plasma and neutrophils. Two additional cohorts of 75 RA patients, treated either with Infliximab (n = 55) or Tocilizumab (n = 20) for six months, were evaluated. RESULTS: NETosis was found increased in RA patients, beside myeloperoxidase and neutrophil elastase protein levels. Cell-free nucleosomes plasma levels were elevated, and strongly correlated with the activity of the disease and the positivity for autoantibodies, alongside inflammatory and oxidative profiles in plasma and neutrophils. Moreover, ROC analyses showed that cell-free nucleosomes levels could identify RA patients showing early atherosclerosis with high specificity. RA patients treated either with IFX or TCZ for six months exhibited decreased generation of NETs. Concomitantly, clinical parameters and serum markers of inflammation were found reduced. Mechanistic in vitro analyses showed that inhibition of NETs extrusion by either DNase, IFX or TCZ, further abridged the endothelial dysfunction and the activation of immune cells, thus influencing the global activity of the vascular system. CONCLUSIONS: NETosis-derived products may have diagnostic potential for disease activity and atherosclerosis, as well as for the assessment of therapeutic effectiveness in RA.


Assuntos
Artrite Reumatoide/complicações , Aterosclerose/diagnóstico , Aterosclerose/etiologia , Armadilhas Extracelulares/metabolismo , Idoso , Antirreumáticos/uso terapêutico , Aterosclerose/terapia , Biomarcadores , Estudos de Casos e Controles , Comorbidade , Feminino , Humanos , Mediadores da Inflamação/metabolismo , Interleucina-6/antagonistas & inibidores , Interleucina-6/metabolismo , Masculino , Pessoa de Meia-Idade , Estresse Oxidativo , Peroxidase , Curva ROC , Fatores de Risco , Índice de Gravidade de Doença , Resultado do Tratamento , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/metabolismo
10.
J Thromb Haemost ; 14(12): 2410-2418, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27681307

RESUMO

Essentials Vitamin K-dependent coagulant factor deficiency (VKCFD) is a rare autosomal recessive disorder. We describe a case of inherited VKCFD due to uniparental disomy. The homozygous mutation caused the absence of GGCX isoform 1 and overexpression of Δ2GGCX. Hepatic and non-hepatic vitamin K-dependent proteins must be assayed to monitor VKCFD treatment. SUMMARY: Background Inherited deficiency of all vitamin K-dependent coagulant factors (VKCFD) is a rare autosomal recessive disorder caused by mutations in the γ-glutamyl carboxylase gene (GGCX) or the vitamin K epoxide reductase gene (VKORC1), with great heterogeneity in terms of both clinical presentation and response to treatment. Objective To characterize the molecular basis of VKCFD in a Spanish family. Methods and Results Sequencing of candidate genes, comparative genomic hybridization and massive sequencing identified a new mechanism causing VKCFD in the proband. Uniparental disomy (UPD) of chromosome 2 caused homozygosity of a mutation (c.44-1G>A) resulting in aberrant GGCX splicing. This change contributed to absent expression of the mRNA coding for the full-length protein, and to four-fold overexpression of the smaller mRNA isoform lacking exon 2 (Δ2GGCX). Δ2GGCX might be responsible for two unexpected clinical observations in the patient: (i) increased plasma osteocalcin levels following vitamin K1 supplementation; and (ii) a mild non-bleeding phenotype. Conclusions Our study identifies a new autosomal disease, VKCFD1, caused by UPD. These data suggest that the Δ2GGCX isoform may retain enzymatic activity, and strongly encourage the evaluation of both hepatic and non-hepatic vitamin K-dependent proteins to assess differing responses to vitamin K supplementation in VKCFD patients.


Assuntos
Coagulação Sanguínea , Dissomia Uniparental , Vitamina K Epóxido Redutases/deficiência , Vitamina K/metabolismo , Carbono-Carbono Ligases/genética , Hibridização Genômica Comparativa , Feminino , Hemostasia , Homozigoto , Humanos , Lactente , Perda de Heterozigosidade , Masculino , Mutação , Fenótipo , Regiões Promotoras Genéticas , RNA Mensageiro/metabolismo , Espanha , Vitamina K Epóxido Redutases/genética
11.
Sci Rep ; 6: 31375, 2016 08 09.
Artigo em Inglês | MEDLINE | ID: mdl-27502756

RESUMO

MicroRNAs markedly affect the immune system, and have a relevant role in CVD and autoimmune diseases. Yet, no study has analyzed their involvement in atherothrombosis related to APS and SLE patients. This study intended to: 1) identify and characterize microRNAs linked to CVD in APS and SLE; 2) assess the effects of specific autoantibodies. Six microRNAs, involved in atherothrombosis development, were quantified in purified leukocytes from 23 APS and 64 SLE patients, and 56 healthy donors. Levels of microRNAs in neutrophils were lower in APS and SLE than in healthy donors. Gene and protein expression of miRNA biogenesis-related molecules were also reduced. Accordingly, more than 75% of identified miRNAs by miRNA profiling were underexpressed. In monocytes, miR124a and -125a were low, while miR-146a and miR-155 appeared elevated. Altered microRNAs' expression was linked to autoimmunity, thrombosis, early atherosclerosis, and oxidative stress in both pathologies. In vitro treatment of neutrophils, monocytes, and ECs with aPL-IgG or anti-dsDNA-IgG antibodies deregulated microRNAs expression, and decreased miRNA biogenesis-related proteins. Monocyte transfections with pre-miR-124a and/or -125a caused reduction in atherothrombosis-related target molecules. In conclusion, microRNA biogenesis, significantly altered in neutrophils of APS and SLE patients, is associated to their atherothrombotic status, further modulated by specific autoantibodies.


Assuntos
Síndrome Antifosfolipídica/sangue , Lúpus Eritematoso Sistêmico/sangue , MicroRNAs/sangue , Trombose/sangue , Adulto , Autoanticorpos/sangue , Biomarcadores/metabolismo , Espessura Intima-Media Carotídea , Estudos de Casos e Controles , Biologia Computacional , Epigênese Genética , Feminino , Humanos , Imunoglobulina G/sangue , Inflamação , Leucócitos/citologia , Masculino , Pessoa de Meia-Idade , Monócitos/citologia , Neutrófilos/metabolismo , Estresse Oxidativo , Transfecção
12.
J Thromb Haemost ; 14(6): 1226-37, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26999003

RESUMO

UNLABELLED: Essentials Estrogens are known to influence the expression of microRNAs in breast cancer cells. We looked at microRNAs in estrogenic regulation of tissue factor pathway inhibitor α (TFPIα). Estrogen upregulated microRNA-27a/b and microRNA-494 through the estrogen receptor α. MicroRNA-27a/b and microRNA-494 are partly involved in estrogenic downregulation of TFPIα. SUMMARY: Background Tissue factor pathway inhibitor (TFPI) has been linked to breast cancer pathogenesis. We have recently reported TFPI mRNA levels to be downregulated by estrogens in a breast cancer cell line (MCF7) through the estrogen receptor α (ERα). Accumulating evidence also indicates that activation of ERα signaling by estrogens may modulate the expression of target genes indirectly through microRNAs (miRNAs). Objectives To examine if miRNAs are involved in the estrogenic downregulation of TFPIα. Methods Computational analysis of the TFPI 3'-untranslated region (UTR) identified potential binding sites for miR-19a/b, miR-27a/b, miR-494, and miR-24. Transient overexpression or inhibition of the respective miRNAs was achieved by transfection of miRNA mimics or inhibitors. Direct targeting of TFPI 3'-UTR by miR-27a/b and miR-494 was determined by luciferase reporter assay in HEK293T cells. Effects of 17α-ethinylestradiol (EE2) and fulvestrant on relative miR-27a/b, miR-494, and TFPI mRNA levels in MCF7 cells were determined by qRT-PCR and secreted TFPIα protein by ELISA. Transient knockdown of ERα was achieved by siRNA transfection. Results EE2 treatment lead to a significant increase in miR-19a, miR-27a/b, miR-494, and miR-24 mRNA levels in MCF7 cells through ERα. miR-27a/b and miR-494 mimics lead to reduced TFPI mRNA and protein levels. Luciferase assay showed direct targeting of miR-27a/b and miR-494 on TFPI mRNA. Impaired estrogen-mediated downregulation of TFPI mRNA was detected in anti-miR-27a/b and anti-miR-494 transfected cells. Conclusions Our results provide evidence that miR-27a/b and miR-494 regulate TFPIα expression and suggest a possible role of these miRNAs in the estrogen-mediated downregulation of TFPIα.


Assuntos
Regulação para Baixo , Estrogênios/química , Lipoproteínas/metabolismo , MicroRNAs/metabolismo , Regiões 3' não Traduzidas , Sítios de Ligação , Linhagem Celular Tumoral , Receptor alfa de Estrogênio/metabolismo , Estrogênios/metabolismo , Fator Xa/química , Células HEK293 , Humanos , Células MCF-7 , Ligação Proteica , Transfecção
13.
Rev. Méd. Clín. Condes ; 26(1): 81-87, ene-feb. 2015. tab
Artigo em Espanhol | LILACS | ID: biblio-1150749

RESUMO

La adolescencia es una etapa de la vida durante la cual se desarrolla la identidad sexual. En este período muchas adolescentes inician su actividad sexual. Por ello, es de vital importancia entregarles consejería, que debe considerar prevención de embarazo e infecciones de transmisión sexual, prevención de conductas de riesgo y favorecer la adquisición de conductas protectoras. El objetivo del presente artículo es entregar una propuesta de consejería integral enfocada en adolescentes. Está dirigido a los profesionales de la salud que tienen el enorme desafío y la responsabilidad de prevenir el embarazo no planificado y las infecciones de transmisión sexual; y apoyar a los adolescentes en el desarrollo de una sexualidad sana.


The adolescence is a stage of life where sexual identity develops. In this period many teenagers become sexually active, so it is vital counseling in pregnancy prevention and sexuality transmitted diseases, as well as in risk behavior, creating in the adolescents the acquisition of protective behaviors. The aim of this article is to provide a proposal for comprehensive counseling adolescents to health professionals that works with them and have the enormous challenge and responsibility not only in pregnancy prevention as well as sexually transmitted disease, also in helping adolescents in the developing of a healthy sexuality.


Assuntos
Humanos , Adolescente , Comportamento Sexual/fisiologia , Sexualidade/fisiologia , Aconselhamento/métodos , Comportamento Sexual/classificação , Abstinência Sexual , Chile , Comportamento do Adolescente/fisiologia
14.
Rev. Méd. Clín. Condes ; 26(1): 88-93, ene-feb. 2015. tab
Artigo em Espanhol | LILACS | ID: biblio-1150772

RESUMO

La sospecha de Síndrome de Ovario Poliquístico es un motivo de consulta frecuente durante la adolescencia, esto probablemente está dado por la sobreposición de las características fisiológicas de este período con los criterios diagnósticos tradicionalmente usados para definir este síndrome, tales como ciclos menstruales irregulares, hiperandrogenismo y morfología ecográfica de ovario poliquístico. Es por esto que parece importante discutir si los criterios diagnósticos de Síndrome de Ovario Poliquístico aplicados en mujeres adultas pueden extrapolarse a los primeros años postmenarquia. En este artículo se discute el diagnóstico de Síndrome de Ovario Poliquístico en la adolescencia, sus controversias y su manejo.


The suspicion of polycystic ovary syndrome is a common complaint during adolescence, and is probably given by the overlap of physiological characteristics of this period of life with the diagnostic criteria traditionally used to define this syndrome, such as irregular menstrual cycles, hyperandrogenism and polycystic ovarian morphology. This is why it seems important to discuss whether these diagnostic criteria for polycystic ovary syndrome in adults can be extrapolated to the early years postmenarche. This article will discuss the diagnosis of polycystic ovary syndrome in adolescence, their controversies and their management.


Assuntos
Humanos , Feminino , Adolescente , Síndrome do Ovário Policístico/diagnóstico , Síndrome do Ovário Policístico/epidemiologia , Síndrome do Ovário Policístico/classificação , Sinais e Sintomas , Chile , Causalidade , Hiperandrogenismo
15.
Artigo em Espanhol | LILACS | ID: lil-783349

RESUMO

La patología mamaria en el grupo de niñas y adolescentes es poco frecuente, correspondiendo generalmente a lesiones benignas, sin embargo, crea gran ansiedad en la paciente y su grupo familiar .El propósito del presente artículo es en base a un caso clínico larevisión de la patología mamaria benigna más frecuente en este grupo etario, las imágenes y su tratamiento...


Pediatric and adolescents breast masses are relatively rare, and most are benign, nevertheless, is very disconcerting in the patient and her family. The purpose of this article is based on a case review the benign breast conditions, the imaging findings and treatmentstrategies in this population...


Assuntos
Humanos , Adolescente , Feminino , Fibroadenoma/tratamento farmacológico , Fibroadenoma , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama
16.
Med. intensiva (Madr., Ed. impr.) ; 37(7): 476-484, oct. 2013. tab
Artigo em Espanhol | IBECS | ID: ibc-121375

RESUMO

Síndrome de distrés mitocondrial y de la microcirculación (SDMM) es una entidad que puede aparecer en el curso del síndrome de respuesta inflamatoria sistémica (SRIS), que se caracteriza por una hipoxia tisular citopática no corregible con la optimización del transporte de oxígeno, asociada a un defecto adquirido para la utilización de oxígeno y producción de energía en la mitocondria y que da lugar a disfunción múltiple de órganos (DMO).Abordamos la etiopatogenia del SDMM, los nuevos métodos para su diagnóstico y los recientes enfoques terapéuticos adaptados a cada una de las 3 fases de su evolución. En la fase inicial lo que se persigue es la prevención y reversión precoz de la disfunción mitocondrial. Una vez esta ya está establecida, el objetivo es restaurar el flujo de la cadena de electrones, la respiración mitocondrial y evitar el colapso energético celular. En la tercera etapa, de resolución, el tratamiento debe ir dirigido a estimular la biogénesis mitocondrial y la reparación o sustitución de las mitocondrias dañadas (AU)


Mitochondrial and microcirculatory distress syndrome (MMDS) can occur during systemic inflammatory response syndrome (SIRS), and is characterized by cytopathic tissue hypoxia uncorrected by oxygen transport optimization, and associated with an acquired defect in the use of oxygen and energy production in mitochondria, leading to multiple organ dysfunction (MOD).We examine the pathogenesis of MMDS, new diagnostic methods, and recent therapeutic approaches adapted to each of the three phases in the evolution of the syndrome. In the initial phase, the aim is prevention and early reversal of mitochondrial dysfunction. Once the latter is established, the aim is to restore flow of the electron chain, mitochondrial respiration, and to avoid cellular energy collapse. Finally, in the third (resolution) stage, treatment should focus on stimulating mitochondrial biogenesis and the repair or replacement of damaged mitochondria (AU)


Assuntos
Humanos , Doenças Mitocondriais/fisiopatologia , Microcirculação/fisiologia , Síndrome de Resposta Inflamatória Sistêmica/fisiopatologia , Insuficiência de Múltiplos Órgãos/fisiopatologia , Hipóxia Celular/fisiologia , Antioxidantes/uso terapêutico , Óxido Nítrico/análise , Espécies Reativas de Oxigênio/análise
17.
Med Intensiva ; 37(7): 476-84, 2013 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-24018281

RESUMO

Mitochondrial and microcirculatory distress syndrome (MMDS) can occur during systemic inflammatory response syndrome (SIRS), and is characterized by cytopathic tissue hypoxia uncorrected by oxygen transport optimization, and associated with an acquired defect in the use of oxygen and energy production in mitochondria, leading to multiple organ dysfunction (MOD). We examine the pathogenesis of MMDS, new diagnostic methods, and recent therapeutic approaches adapted to each of the three phases in the evolution of the syndrome. In the initial phase, the aim is prevention and early reversal of mitochondrial dysfunction. Once the latter is established, the aim is to restore flow of the electron chain, mitochondrial respiration, and to avoid cellular energy collapse. Finally, in the third (resolution) stage, treatment should focus on stimulating mitochondrial biogenesis and the repair or replacement of damaged mitochondria.


Assuntos
Microcirculação/fisiologia , Doenças Mitocondriais/etiologia , Síndrome de Resposta Inflamatória Sistêmica/complicações , Animais , Antioxidantes/uso terapêutico , Hipóxia Celular , Progressão da Doença , Transporte de Elétrons/efeitos dos fármacos , Metabolismo Energético/efeitos dos fármacos , Sequestradores de Radicais Livres/uso terapêutico , Hemodinâmica , Hibernação , Humanos , Hipotermia Induzida , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/fisiologia , Doenças Mitocondriais/diagnóstico , Doenças Mitocondriais/fisiopatologia , Modelos Animais , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/fisiopatologia , Insuficiência de Múltiplos Órgãos/prevenção & controle , Óxido Nítrico/fisiologia , Óxido Nítrico/uso terapêutico , Fosforilação Oxidativa/efeitos dos fármacos , Espécies Reativas de Oxigênio , Síndrome , Síndrome de Resposta Inflamatória Sistêmica/fisiopatologia
18.
Sci Rep ; 3: 1434, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23486377

RESUMO

The standard pathway for virus infection of eukaryotic cells requires disassembly of the viral shell to facilitate release of the viral genome into the host cell. Here we use mechanical fatigue, well below rupture strength, to induce stepwise disruption of individual human adenovirus particles under physiological conditions, and simultaneously monitor disassembly in real time. Our data show the sequence of dismantling events in individual mature (infectious) and immature (noninfectious) virions, starting with consecutive release of vertex structures followed by capsid cracking and core exposure. Further, our experiments demonstrate that vertex resilience depends inextricably on maturation, and establish the relevance of penton vacancies as seeding loci for virus shell disruption. The mechanical fatigue disruption route recapitulates the adenovirus disassembly pathway in vivo, as well as the stability differences between mature and immature virions.


Assuntos
Adenovírus Humanos/fisiologia , Estresse Mecânico , Adenovírus Humanos/química , Capsídeo/química , Capsídeo/fisiologia , Proteínas do Capsídeo/metabolismo , Humanos , Microscopia de Força Atômica , Simulação de Dinâmica Molecular , Montagem de Vírus
19.
Med. intensiva (Madr., Ed. impr.) ; 37(2): 99-109, mar. 2013. tab
Artigo em Espanhol | IBECS | ID: ibc-113783

RESUMO

La Hipertensión Intraabdominal (HIA) y el Síndrome Compartimental Abdominal (SCA) son entidades frecuentes en los pacientes graves y cursan con una alta mortalidad. En esta revisión se actualizan los aspectos más debatidos sobre la HIA y el SCA: factores desencadenantes, epidemiología, pronóstico, métodos de medición de la presión intraabdominal (PIA), consecuencias fisiopatológicas y medidas terapéuticas, tanto médicas como quirúrgicas. Se plantea que, simultáneamente a los mecanismos de lesión estrictamente físicos, como la compresión directa de vasos y órganos intraabdominales, la transmisión de la PIA a otros compartimentos y el descenso del gasto cardíaco, pueden intervenir también una serie de mediadores inmunoinflamatorios generados en el propio intestino. La hipoperfusión, la isquemia mantenida y el fenómeno isquemia-reperfusión actuarían sobre la microbiota, el epitelio y sistema inmune intestinal desencadenando el Síndrome de Distrés Intestinal Agudo, una respuesta inflamatoria sistémica y una eventual disfunción multiorgánica que pueden aparecer en fases tardías del SCA (AU)


Seriously ill patients frequently present intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) as complications, and the associated mortality is very high. This review offers an update on the most controversial aspects of these entities: factors favoring their appearance, the most common causes, prognosis, and methods of measuring intra-abdominal pressure (IAP), physiopathological consequences in relation to the different organs and systems, and the currently accepted treatment measures (medical and/or surgical). Simultaneously to the strictly physical mechanisms of injury, such as direct compression of intra-abdominal organs and vessels, the transmission of IAP to other compartments, and the drop in cardiac output, a series of immune-inflammatory mediators generated in the intestine itself may also intervene. Hypoperfusion, sustained ischemia and the ischemia-reperfusion phenomenon, would act upon the microbiota, intestinal epithelium and intestinal immune system, triggering a systemic inflammatory response and multiorgan dysfunction that appears in the final stages of ACS (AU)


Assuntos
Humanos , Síndromes Compartimentais/complicações , Enteropatias/complicações , Hipertensão Intra-Abdominal/complicações , Fatores de Risco , Estado Terminal , Síndrome de Resposta Inflamatória Sistêmica/complicações
20.
Med Intensiva ; 37(2): 99-109, 2013 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-22244213

RESUMO

Seriously ill patients frequently present intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) as complications, and the associated mortality is very high. This review offers an update on the most controversial aspects of these entities: factors favoring their appearance, the most common causes, prognosis, and methods of measuring intra-abdominal pressure (IAP), physiopathological consequences in relation to the different organs and systems, and the currently accepted treatment measures (medical and/or surgical). Simultaneously to the strictly physical mechanisms of injury, such as direct compression of intra-abdominal organs and vessels, the transmission of IAP to other compartments, and the drop in cardiac output, a series of immune-inflammatory mediators generated in the intestine itself may also intervene. Hypoperfusion, sustained ischemia and the ischemia-reperfusion phenomenon, would act upon the microbiota, intestinal epithelium and intestinal immune system, triggering a systemic inflammatory response and multiorgan dysfunction that appears in the final stages of ACS.


Assuntos
Enteropatias/etiologia , Hipertensão Intra-Abdominal/complicações , Doença Aguda , Humanos , Hipertensão Intra-Abdominal/etiologia , Hipertensão Intra-Abdominal/fisiopatologia , Hipertensão Intra-Abdominal/terapia , Fatores de Risco , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...